( en | de | ru )

 

Disambiguation of "Warnat, Patrick"

Author of the publication

copydeleteadd this publication to your clipboard
Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.

, , , , , , , , , , , , , and . J Clin Oncol, 24 (31): 5070--5078 (November 2006)
DOI: 10.1200/JCO.2006.06.1879

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Patrick René Warnat

Stephan Warnat

Jan Warnat

Rebecca Judith Langlois-Warnat

Silke Erna Frieda Warnat

 

Other publications of authors with the same name

Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes., , , , , and . BMC Cancer, (2007)Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease., , , , , , , , , and 1 other author(s). Cancer Lett, 250 (2): 250--267 (June 2007)Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer., , , , , , , , , and 5 other author(s). J Clin Oncol, 24 (12): 1839--1845 (April 2006)Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes., , and . BMC Bioinform., (2005)Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome., , , , , , , , , and . Clin Cancer Res, 12 (17): 5118--5128 (September 2006)Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification., , , , , , , , , and 4 other author(s). J Clin Oncol, 24 (31): 5070--5078 (November 2006)Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling., , , , , , , , , and 2 other author(s). Oncogene, 24 (53): 7902--7912 (November 2005)